Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 945714, 9 pages
http://dx.doi.org/10.1155/2012/945714
Research Article

Suppressive Effect of Juzentaihoto on Vascularization Induced by B16 Melanoma Cells In Vitro and In Vivo

Department of Physiology, School of Medicine, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan

Received 20 June 2011; Accepted 23 August 2011

Academic Editor: Yoshiyuki Kimura

Copyright © 2012 Shintaro Ishikawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Utsuyama, H. Seidlar, M. Kitagawa, and K. Hirokawa, “Immunological restoration and anti-tumor effect by Japanese herbal medicine in aged mice,” Mechanisms of Ageing and Development, vol. 122, no. 3, pp. 341–352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Matsumoto, M. Sakurai, H. Kiyohara, and H. Yamada, “Orally administered decoction of Kampo (Japanese herbal) medicine, “Juzen-Taiho-To” modulates cytokine secretion and induces NKT cells in mouse liver,” Immunopharmacology, vol. 46, no. 2, pp. 149–161, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Higuchi, Y. Shimizu, T. TYasumura, and A. Watanabe, “Preventive effect of liver carcinogenesis by Juzen-Taiho-To in the patients with liver cirrhosis,” Liver, Gallbladder, and Pancreas, vol. 44, pp. 341–346, 2002. View at Google Scholar
  4. K. Sasaki, H. Takasaka, and K. Hirata, “Suppressive effect of Kampo Japanese Herbal Medicine on hepatic tumor metastasis,” Japanese Journal of Cancer Clinics, vol. 48, pp. 171–176, 2002. View at Google Scholar
  5. S. Ohkawa and K. Tarao, “The prevention of hepatocellular carcinoma development by the improvement of serum transaminase in patients with Hepatitis C.,” Clinical Gastroenterology, vol. 21, pp. 318–323, 2006. View at Google Scholar
  6. J. Folkman, “What is the evidence that tumors are angiogenesis dependent?” Journal of the National Cancer Institute, vol. 82, no. 1, pp. 4–6, 1990. View at Google Scholar · View at Scopus
  7. T. Veikkola and K. Alitalo, “VEGFs, receptors and angiogenesis,” Seminars in Cancer Biology, vol. 9, no. 3, pp. 211–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. L. F. Brown, A. J. Guidi, S. J. Schnitt et al., “Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast,” Clinical Cancer Research, vol. 5, no. 5, pp. 1041–1056, 1999. View at Google Scholar · View at Scopus
  9. J. S. de Jong, P. J. van Diest, P. van der Valk, and J. P. Baak, “Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: an inventory in search of autocrine and paracrine loops,” Journal of Pathology, vol. 184, no. 1, pp. 44–52, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Matsuda, K. Maekawa, K. Asano, and T. Hisamitsu, “Suppressive effect of Juzen-Taiho-To on lung metastasis of B16 melanoma cells in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 743153, 5 pages, 2011. View at Google Scholar
  11. S. Ishikawa, M. Sunagawa, T. Kubo et al., “Influence of Chinese herbal medicine on reactive oxygen and blood fluidity in rats,” Kampo Medicine, vol. 62, no. 3, pp. 337–346, 2011. View at Google Scholar
  12. M. Asagiri, T. Hirai, T. Kunigami et al., “Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis,” Science, vol. 319, no. 5863, pp. 624–627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. C. H. John, “The effect of subcutaneous tumour implantation in a murine lung tumour model,” European Journal of Cardio-Thoracic Surgery, vol. 21, no. 4, pp. 616–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Yoshii, “Inhibitory effects of ulinastain on tumor cell induced angiogenosis,” Dokkyo University School of Medicine, vol. 32, no. 1, pp. 47–56, 2005. View at Google Scholar
  15. P. V. Leyon and G. Kuttan, “Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals,” International Immunopharmacology, vol. 4, no. 13, pp. 1569–1575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Kishi, S. Petersen, C. Petersen et al., “Preferential enhancement of tumor radio response by COX-2 inhibition,” Cancer Research, vol. 60, pp. 1326–1331, 2000. View at Google Scholar
  17. S. Dandamudi, V. Patil, W. Fowle, B. A. Khaw, and R. B. Campbell, “External magnet improves antitumor effect of vinblastine and the suppression of metastasis,” Cancer Science, vol. 100, no. 8, pp. 1537–1543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Tsunoda, T. Nakamura, H. Sakurai, and I. Saiki, “Fibroblast growth factor-2-induced host stroma reaction during initial tumor growth promotes progression of mouse melanoma via vascular endothelial growth factor A-dependent neovascularization,” Cancer Science, vol. 98, no. 4, pp. 541–548, 2007. View at Google Scholar · View at Scopus
  19. E. Swartzman, M. Shannon, P. Lieu et al., “Expanding applications of protein analysis using proximity ligation and qPCR,” Methods, vol. 50, no. 4, pp. S23–S26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. C. Barbacioru, Y. Wang, R. D. Canales et al., “Effect of various normalization methods on applied Biosystems expression array system data,” BMC Bioinformatics, vol. 7, article 533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Martínez, M. Sánchez-Lopez, J. Varadé et al., “Role of the MHC2TA gene in autoimmune diseases,” Annals of the Rheumatic Diseases, vol. 66, no. 3, pp. 325–329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. P. Kósa, A. Kis, K. Bácsi et al., “The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells,” Bone, vol. 48, no. 5, pp. 1052–1057, 2011. View at Publisher · View at Google Scholar
  23. K Handa, N Kawamura, and S Takahashi, “Case report,” Kampo Medicine, vol. 29, pp. 215–220, 2005. View at Google Scholar
  24. R. Kerbel and J. Folkman, “Clinical translation of angiogenesis inhibitors,” Nature Reviews Cancer, vol. 2, no. 10, pp. 727–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. L. E. Benjamin, D. Golijanin, and A. Itin, “Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal,” Journal of Clinical Investigation, vol. 103, no. 2, pp. 159–165, 1999. View at Google Scholar · View at Scopus
  26. T. Veikkola and K. Alitalo, “VEGFs, receptors and angiogenesis,” Seminars in Cancer Biology, vol. 9, no. 3, pp. 211–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. G. McMahon, “VEGF receptor signaling in tumor angiogenesis,” Oncologist, vol. 5, no. 1, pp. 3–10, 2000. View at Google Scholar · View at Scopus
  28. V. K. Kommineni, C. N. Nagineni, A. William, B. Detrick, and J. J. Hooks, “IFN-γ acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1,” Biochemical and Biophysical Research Communications, vol. 374, no. 3, pp. 479–484, 2008. View at Google Scholar